Rock, you're talking to the wrong person. You need to follow up with Scott Kelly. Please send what you have written here to him. There's no need for me to be the conduit between you and him.
Do you happen to know Dr. Ken Sherman of University of Cincinnati? You might want to correspond with him also.
This is the way I introduced you to Nader and Scott -
"There's a shareholder, a doctor, who goes by the moniker of Rockleo on the Investors Hub message board, who is currently the principal investigator in a NASH trial, and previously has been the PI in several other NASH trials, who disagrees with the way that CytoDyn is conducting its NASH trial. This doctor owns over 800,000 shares of CYDY."
And then I repeated what you had stated here.
The ball is in your court now.
News 
Market Data 
Discover 
AI
